Prostate Cancer News

Intuitive Surgical Inc. prevailed at a trial against claims it was negligent in its training of a doctor who performed a robot-assisted surgery on a patient who later died.

Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression.

ConsumerAffairs' culture and lifestyle reporter, Daryl Nelson has written for Readers Digest, Townsquare Media, AllHipHop.com and a number of other online and print publications.

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

A TUTOR led dozens of people on a course all about cancer - and then realised he had the symptoms himself.

Some prostate cancer patients unnecessarily undergo surgery or harsh treatments because science fails to identify the differences between slow-growing and aggressive forms of the disease.

Northwest Biotherapeutics , a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced today that it will use its exhibit at this year's American Society Of Clinical Oncology meeting in Chicago to highlight its leadership role in immune therapy.

The analysis of exonic DNA from prostate cancers has identified recurrently mutated genes, but the spectrum of genome-wide alterations has not been profiled extensively in this disease.

Merrion Pharmaceuticals Plc is a pharmaceutical company. It carries out the development of innovative tablets/capsules of drugs with incomparable absorption.

Mayo Clinic has teamed up with a New Jersey company to create a joint venture that aims to create diagnostic cancer tests that use gene-sequencing technology.

Two years ago drugmakers spent 14-million dollars promoting prescription testosterone.

After more than a decade of work, UC Irvine chemists have created a way to clearly identify clinically usable markers for prostate cancer in urine, meaning that the disease could be detected far sooner, with greater accuracy and at dramatically lower cost.

Since the "Desperate Housewives" finale aired last May, Marcia Cross has stayed mostly low-key. But when she was asked to participate in a PSA to promote prostate cancer awareness, she says it was a "no-brainer" because her close friend's husband had been diagnosed with the disease.

California's HealthCare Foundation releases an update to its searchable map allowing residents and doctors to search and compare the frequency of more procedures in communities throughout the state.

A new test for prostate cancer without the need for biopsies is being developed thanks to a collaboration between Royal Berkshire Hospital and Reading University.

A loophole in California's upcoming health care overhaul could be exploited by families gaming the system or responding to hardship in a way that doctors say could leave a pile of unpaid bills.

Dear Dr. Roach: Could you help explain the preponderance of testosterone-enhancing drugs that I see advertised lately for 'low male libido'? Do they contain anabolic steroids, and if so, shouldn't they be prescribed under the strictest medical supervision and for reasons other than 'low male libido'? The first is the actual prescribed testosterone, ... (more)

Aggressive treatment for prostate cancer may not be warranted for many older patients with underlying medical conditions, a new study finds.

Background:The Prostate Cancer Prevention Trial has shown a protective effect of finasteride on prostate cancer in low-risk men.

Accuray Incorporated , announced today the publication of study results involving hundreds of prostate cancer patients treated with the CyberKnife Robotic Radiosurgery System, the most widely used form of prostate stereotactic body radiation therapy .